The Belfast Telegraph has reported that CoFund portfolio company Fusion Antibodies is set to list on the AIM market.

CV6 Therapeutics Named Therapeutics Innovation of the Year
Belfast-based CV6 Therapeutics has won Therapeutics Innovation of the Year at the 2026 BioTech Breakthrough Awards for its investigational cancer medicine, CV6-168.
